Related Experiment Video
Updated: Dec 27, 2025

05:57
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025
863
Tracking significant modules and key genes for esophageal squamous cell carcinoma based on differential modules
Meng-Li Zheng1, Nai-Kang Zhou2, Cheng-Hua Luo3
1Department of Chest Surgery, The 309th Hospital, PLA, Beijing 100091, China.
Journal of Cancer Research and Therapeutics
|December 13, 2018
Summary
This study identified four key molecular pathways and myeloperoxidase (MPO) as crucial in esophageal squamous cell carcinoma (ESCC) development, offering potential biomarkers for diagnosis and treatment.
Area of Science:
- Oncology
- Bioinformatics
- Molecular Biology
Background:
- The molecular mechanisms driving esophageal squamous cell carcinoma (ESCC) remain largely undefined.
- Significant improvements in ESCC patient prognosis are still needed.
Purpose of the Study:
- To elucidate the molecular mechanisms of ESCC.
- To identify differential modules (DMs) and key genes using a differential co-expression network (DCN) approach.
- To analyze gene expression profiles and protein-protein interaction (PPI) data.
Main Methods:
- Preprocessed gene expression profiles and PPI data for ESCC.
- Constructed a DCN integrating gene co-expression and differential expression data.
- Employed a module searching strategy to identify significant DMs and analyze key genes for potential biomarkers.
Main Results:
- A DCN comprising 915 nodes and 1164 interactions was built from 10,975 genes.
- Four significant DMs were identified, enriched in phenylalanine metabolism, nicotine addiction, and B-cell receptor signaling pathways.
- Myeloperoxidase (MPO) was identified as a key seed gene present in all identified DMs.
Conclusions:
- Successfully identified four DMs and three key pathways implicated in ESCC.
- Highlighted MPO as a critical gene potentially involved in ESCC pathogenesis.
- These findings suggest MPO and identified pathways as potential diagnostic indicators and therapeutic targets for ESCC.

